Medindia
Medindia LOGIN REGISTER
Advertisement

Health Robotics Surpasses 100 Installations Milestone and Acquires Two I.V. Room of the Future Partner Companies

Wednesday, July 28, 2010 Corporate News
Advertisement
BOZEN, SUD-TIROL, Italy, July 27, 2010 Health Roboticsannounced that it has reached final agreements to acquire all assets fromItaly-based MEDarchiver S.r.l. and Biomedical Technology Consulting S.r.l.,merging these companies' employees and operations, re-entering direct salesactivities in the Italian market, and conducting a re-organization of itsExecutive Management, expecting to close these acquisitions over the next fewmonths.
Advertisement

"After Health Robotics' meteoric growth recently surpassed thesignificant milestone of 100 worldwide I.V. Automation contracts, it dictatedthe need to consolidate its market gains by acquiring the assets of these twostrategic partner companies that supplied products and services to HealthRobotics' customers and to the I.V. Room of the Future Project. Theseacquisitions enable Health Robotics to: a) re-establish an IV Room presencein Italy after having temporarily exited the market in 2008 as a result ofthe transfer to Loccioni [CytoCare's development partner] of most of Italy'sCytoCare operations; b) yield long-term cost synergies; and c) consolidatethe three companies' intellectual property, customer-facing operations, andscientific knowledge within the fields of I.V. Automation and ClinicalWorkflow Solutions," stated Werner Rainer, Health Robotics' CEO.
Advertisement

MEDarchiver has built an outstanding reputation over the past decade forexcellence in developing and implementing "All-Digital" life-criticalsoftware automation solutions for healthcare providers with exceptionalinnovation, ease-of-deployment, and R.O.I. results. Amongst others, assetsinclude Cardio Web, the world's first and only nationwide Cardiology digitalmedical record, certified by the National Council of Cardiologists in Italy;OMM, which will serve as the company's cornerstone to expand its CancerTherapy presence in North America, complementing CytoCare and i.v.SOFT; andMEDtpn, which enables Health Robotics to immediately offer TPN e-Prescriptionto its customers, and to develop TPNstation on top of an industrial-strengthTPN workflow software foundation.

In anticipation of these acquisitions, Health Robotics' instituted in Mayand June 2010 changes to its Executive Management Team in order to have itsmembers become more focused in specific areas of competence. Consequently,Fabio Fioravanti [Executive VP for Operations and CTO] assumed in June allresponsibilities encompassing quality assurance, product development,implementation, operations, manufacturing, and customer support; GasparDeViedma ceased his General Counsel duties last May to focus exclusively onsales, product marketing, and joint-development activities worldwide,including MEDarchiver solutions outside of Italy; Paolo Giribona nowexclusively concentrates on research activities related to new products suchas TPNstation; and finally Werner Rainer continues as CEO of Health Roboticswhile exclusively centering his efforts on the I.V. Room of the Future,utilizing MEDarchiver's customer base to re-enter the Italian market for I.V.Automation, and directly supervising the newly formed 10-member HealthRobotics' Scientific Advisory Board, whose contributors will be announced inAugust 2010.

Biomedical Technology Consulting has led technology assessments andworkflow re-design projects in Italy, Germany, France, Luxemburg,Switzerland, Croatia, Serbia, Romania, Albania, U.A.E., Qatar, Iraq, Cyprus,and Vietnam, with extensive experience in the I.V. Room, Pharmacy,Cardiology, Anesthesiology, PACS, and Nursing segments.

Expected immediate synergies from the merged companies include a singlecustomer help-desk; integrated R&D, quality assurance and production teams;one-stop distribution channels; and the acquisition of key personnel assets.MEDarchiver will continue to operate as a division of Health Robotics,focusing on integrated and "All-Digital" workflow automation solutions in itsestablished local markets, while benefiting from exporting best-of-classOncology, Cardiology and other medical error-avoidance technology solutionsthroughout Health Robotics' worldwide distribution network. Health Roboticswill continue investing into and expanding MEDarchiver markets, andshowcasing its "All-Digital" healthcare installations, such as CampusBiomedico University Hospital and La Maddalena Cancer Institute. For moreinformation, please visit: http://www.medarchiver.com

About Health Robotics:

Health Robotics is the undisputed global leading supplier oflife-critical intra-venous medication robots, providing healthcare facilitiesin 5 continents with robotics technology and software automation solutionsdeployed utilizing virtual high-availability technology. Its world-leadingsolutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs],i.v.SOFT(TM) [manual compounding software], MEDarchiver(TM) [clinicalinformation system], and TPNstation(TM) [totally-automated parenteralnutrition] have and will greatly contribute to ease hospitals' growingpressures to improve patient safety, increase throughput and contain costs.Through the effective and efficient production of sterile, accurate,tamper-evident and ready-to-administer IVs, Health Robotics' solutions helphospitals eliminate life-threatening drug-exchange errors, decrease othermedical errors and sterility risks, work more efficiently, reduce waste andcontrolled substances' diversion, and diminish the gap between rising patientvolume/acuity and scarce medical, nursing, and pharmacy staff.

For more company information including a corporate video, please visithttp://www.health-robotics.com/en/about-health-robotics/. For additionalinformation, please contact:Health Robotics S.r.l. Claudia Flaim, Marketing Coordinator Phone: +39-0471-200-372 [email protected]

SOURCE Health Robotics
Sponsored Post and Backlink Submission


Latest Press Release on Corporate News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close